Results 121 to 130 of about 175,097 (273)

A Framework Analysis of Electronic Bladder Diary Apps: Suitability for Clinical Decision‐Making and Comparison to Validated Paper Diaries

Neurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Bladder diaries aid physicians in diagnosis and treatment of lower urinary tract symptoms and bladder conditions, but perceived burden of documentation can compromise completion of paper diaries. Perceived benefits of electronic diaries over paper diaries include ease of use and the option to export and share data. The aim of this
Ceilidh Matthews, Lynn Stothers, Christine Burke, Kelsey Petersen, Andrew Macnab   +4 more
wiley   +1 more source

Choice of antimuscarinic agents for overactive bladder in the older patient: focus on darifenacin

, 2008
Bilal Chughtai1, Robert Levin2, Elise De11Albany Medical College, Division of Urology; 2Albany College of Pharmacy and Stratton VAMC, Albany, NY, USAAbstract: Overactive bladder (OAB) is a difficult condition to live with and is very costly tothe ...
Bilal Chughtai, Robert Levin, Elise De
core  

Overactive bladder: epidemiology and social impact

, 2005
Purpose of review Overactive bladder epidemiology is a rapidly evolving field. The new terminology of lower urinary tract function, introduced in 2002, modified-the definitions of all four components of overactive bladder.
PALLESCHI, GIOVANNI, TUBARO, ANDREA
core   +1 more source

The Benefits of Adding Non‐Antimuscarinic Pharmaceuticals in Combination With Beta‐3 Agonists for Overactive Bladder Treatment: A Systematic Review

Neurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Antimuscarinics, as the current first‐line pharmacologic therapies for overactive bladder, exhibit low patient adherence and high rates of reported side effects. As a modern alternative pharmaceutical treatment, beta‐3 agonists, which relax the urinary bladder, may be more tolerable for patients, increasing adherence and ...
Felicity Smith, Charlotte Phelps, Christian Moro   +2 more
wiley   +1 more source

BEHAVIORAL THERAPY FOR OVERACTIVE BLADDER

BJU International, 2000
ABSTRACT What is behavioral therapy? On the one hand there is no consensus in the literature as to the definition of the treatment or the optimal mode of delivery. On the other hand, it is possibly the “best” single treatment for urinary incontinence when viewed from a risk:benefit analysis. There is general agreement that within this
openaire   +2 more sources

Determinants of Estrogen Prescriptions for Recurrent Urinary Tract Infections

Neurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Vaginal estrogen is a highly effective, evidence‐based prevention method for postmenopausal women with recurrent urinary tract infections (UTIs), yet studies suggest its underutilization by non‐specialist providers. Guided by the Consolidated Framework for Implementation Research (CFIR), this study examined adoption, fidelity, and
Kelly F. Oechsel, Lei A. Qin, Minyoung Jang, Nathanael Koelper, Christine M. Chu, Shafinaz Akhter, Lily A. Arya   +6 more
wiley   +1 more source

Comparison of the effects of transcranial direct current stimulation and transcutaneous tibial nerve stimulation on the urgency and frequency of women with overactive bladder syndrome: study protocol of a randomized clinical trial

Trials
Background Overactive bladder syndrome is common, with a prevalence of 12–17% among adults. Posterior tibial nerve stimulation is the primary nonpharmacological and conservative treatment for overactive bladder syndrome. While several human brain imaging
Zahra Gorji, MohammadReza Hadian Rasanani, Michael Nitsche, Tannaz Ahadi, Roya Khanmohammadi, Mona Gorji, Roxana Bazaz Behbahani, Vahid Rafiei Manesh   +7 more
doaj   +1 more source

Profile of mirabegron in the treatment of overactive bladder: place in therapy

, 2017
Ala’a Sharaf, Hashim Hashim Female and Functional Urology Unit, Bristol Urological Institute, Bristol, UK Abstract: Mirabegron is a relatively new drug introduced to treat overactive bladder syndrome.
Hashim H, Sharaf A
core  

Functional Roles of Adenosine A2B and A3 Receptor Subtypes in the Bladder of Male Rats With A2B Receptor Deletion or Bladder Outlet Obstruction

Neurourology and Urodynamics, EarlyView.
ABSTRACT Purpose To investigate the adenosine receptor (AR) mechanism underlying bladder outlet obstruction (BOO)‐related bladder dysfunction, we examined the expression level of AR subtypes in bladder tissues, and the effects of AR subtypes A2B & A3 modulation on bladder activity using male BOO rats, and Dahl rats with A2B receptor deletion. Materials
Masahiro Kurobe, Ei‐ichiro Takaoka, Kanako Matsuoka, Shingo Kimura, Anne M. Robertson, Edwin K. Jackson, Lori A. Birder, Minoru Miyazato, Naoki Yoshimura   +8 more
wiley   +1 more source

Oxybutynin extended release for the management of overactive bladder: a clinical review

, 2009
AM Arisco, EK Brantly, SR KrausUniversity of Texas Health Science Center at San Antonio, Department of Urology, San Antonio, Texas, USAAbstract: Overactive bladder (OAB) is a common condition which negatively impacts the quality of life of afflicted ...
EK Brantly, SR Kraus, AM Arisco
core